✦ LIBER ✦

Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer

✍ Scribed by Oliver Sartor; Robert H Reid; Peter J Hoskin; Donald P Quick; Peter J Ell; Robert E Coleman; Jon A Kotler; Leonard M Freeman; Pierre Olivier

Book ID: 116944163
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 144 KB
Volume: 63
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2004.01.034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective Evaluation of Samarium-153-E

Prospective Evaluation of Samarium-153-EDTMP Radionuclide Treatment for Bone Metastases in Patients with Hormone-Refractory Prostate Cancer

✍ Dolezal, J.; Vizda, J.; Odrazka, K. 📂 Article 📅 2007 🏛 S. Karger AG 🌐 English ⚖ 173 KB

Samarium 153 was effective in the treatm

Samarium 153 was effective in the treatment of disseminated intravascular coagulation in a man with hormone-refractory prostate cancer and painful bone metastases,

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Safety Analysis of Repeated High Doses o

Safety Analysis of Repeated High Doses of Samarium-153 Lexidronam in Men with Hormone-Naive Prostate Cancer Metastatic to Bone

✍ Celestia S. Higano; Donald P. Quick; David Bushnell; Oliver Sartor 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 161 KB

Painful bone metastases in hormone-refra

Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy

✍ Irena Malmberg; Ulf Persson; Anders Ask; Jan Tennvall; Per-Anders Abrahamsson 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 821 KB

SUCCESSFUL USE OF SAMARIUM 153 FOR EMERG

SUCCESSFUL USE OF SAMARIUM 153 FOR EMERGENCY TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION DUE TO METASTATIC HORMONE REFRACTORY PROSTATE CANCER

✍ RUFFION, ALAIN; MANEL, ARNAUD; VALIGNAT, CHRISTOPHE; LOPEZ, JEAN G.; PERRIN-FAYO 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 28 KB

Combined use of zoledronic acid and 153S

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases

✍ Marnix G. E. H. Lam; Amel Dahmane; Wil H. M. Stevens; Peter P. van Rijk; John M. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 243 KB